Skip to main content
. 2024 Feb 6;16:28. doi: 10.1186/s13195-024-01396-w

Table 1.

Characteristics of the study population by cardiometabolic disease status (n = 1464)

Total (n = 1464) CMD-free (n = 700) Single CMD (n = 454) CMD multimorbidity (n = 310) P-value
Age, years 61.80 ± 10.16 58.27 ± 9.98 63.42 ± 9.17 67.40 ± 8.75 < 0.001a
Female 629 (42.96%) 287 (41.00%) 207 (45.59%) 135 (43.55%) 0.297b
Education, years 9.49 ± 4.35 9.65 ± 4.25 9.09 ± 4.42 9.70 ± 4.41 0.063a
BMI, kg/m2 25.62 ± 3.75 24.76 ± 3.72 26.20 ± 3.46 26.70 ± 3.79 < 0.001a
Cigarette use, yes 399 (27.30%) 209 (29.94%) 104 (22.96%) 86 (27.83%) 0.033b
Alcohol use, yes 416 (28.50%) 206 (29.47%) 131 (28.92%) 79 (25.57%) 0.434b
Physically active 811 (55.70%) 392 (56.40%) 242 (53.54%) 177 (57.28%) 0.520b
APOE ε4 carriers 191 (15.00%) 82 (13.80%) 62 (15.62%) 47 (16.73%) 0.487b
MMSE 27.75 ± 2.25 27.94 ± 2.19 27.64 ± 2.38 27.51 ± 2.15 0.008a
CSF AD biomarkers
 Aβ42, pg/ml 341.53 ± 212.79 336.90 ± 211.92 341.28 ± 213.52 352.36 ± 213.97 0.533c
 P-tau181, pg/ml 44.15 ± 14.12 42.35 ± 13.32 44.49 ± 13.70 47.70 ± 15.71 < 0.001c
 T-tau, pg/ml 198.54 ± 90.32 186.98 ± 83.14 199.24 ± 87.70 223.60 ± 103.81 < 0.001c
 Aβ42/ Aβ40 0.06 ± 0.05 0.06 ± 0.05 0.06 ± 0.04 0.05 ± 0.03 0.210c
 P-tau181/ Aβ42 0.19 ± 0.17 0.19 ± 0.15 0.20 ± 0.17 0.21 ± 0.20 0.376c
 T-tau/ Aβ42 0.87 ± 0.88 0.81 ± 0.71 0.89 ± 1.01 0.98 ± 1.02 0.0579c

Data are presented as means ± standard deviations or number (proportion %)

Abbreviations: BMI Body mass index, APOE ε4 Apolipoprotein E ε4 allele

aThe difference among the groups was examined by the Kruskal–Wallis test

bThe difference among the groups was examined by the chi-square test

cThe difference among the groups was examined by the analysis of variance (raw data were Box-Cox-transformed). Proportions of missing data: BMI (1.71%), education attainment (0.27%), APOE ε4 (13.11%), cigarette use (0.27%), alcohol use (0.20%), and physical activity (0.55%)